# US 2020/0270690 A1 · Serum/plasma LncRNA marker composition associated with auxiliary diagnosis of intrahepatic cholestasis of pregnancy and application thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0270690 A1
- Document ID: US20200270690A1
- Status: Published application
- Kind: A1
- Application number: 16/781,973
- Filed: 2020-02-04
- Published: 2020-08-27
- Earliest claimed: 2019-02-22
- Assignees: Wuxi Maternity and Child Health Care Hospital
- Applicants: Wuxi Maternity and Child Health Care Hospital
- Inventors: Ting ZHANG; Liang LUO; Jing WANG; Ruirui DONG; Ping ZOU; Shaohan ZOU; Rui YANG; Yao WANG; Na LI; Minjian CHEN; Xina MENG; Yan ZHANG; Conghua ZHOU
- Web page: https://patentgrep.com/patent/US20200270690A1

## CPC

- C12Q 1/6883: for diseases caused by alterations of genetic material
- C12Q 1/686: Polymerase chain reaction [PCR]
- C12Q 2561/113: Real time assay
- C12Q 2600/158: Expression markers
- C12Q 2600/178: miRNA, siRNA or ncRNA
- G01N 2800/085: Liver diseases, e.g. portal hypertension, fibrosis, cirrhosis, bilirubin
- G01N 2800/368: Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

A serum/plasma LncRNA marker composition associated with auxiliary diagnosis of intrahepatic cholestasis of pregnancy and application thereof. The marker is selected from any one of ENST00000449605.1, ASO3480 and ENST00000505175.1. The serum/plasma LncRNA screening and auxiliary diagnosis kit is a LncRNAs diagnostic kit developed based on the specific serum/plasma LncRNA of ICP cases and healthy controls.

## Claims

### Claim 1

A diagnostic kit for detecting an intrahepatic cholestasis of pregnancy in a sample of a subject comprising a reverse transcriptase, a DNA polymerase, dNTPs, a buffer and at least one pair of primers capable of amplifying one fragment of DNA from cDNA of an ENST00000449605.1, ASO3480 or ENST00000505175.1.

### Claim 2 (depends on 1)

The diagnostic kit according to claim 1, wherein the ENST00000449605.1, ASO3480 and ENST00000505175.1 are RNAs whose cDNAs having DNA sequences shown as SEQ ID NO: 7, SEQ ID NO: 8 and SEQ ID NO: 9, respectively.

### Claim 3 (depends on 2)

The diagnostic kit according to claim 2, wherein the pair of primers has the DNA sequences shown in SEQ ID No. 1 and SEQ ID No. 2, in SEQ ID No. 3 and SEQ ID No. 4 or in SEQ ID No. 5 and SEQ ID No. 6 which amplifies the fragment of DNA from the cDNA of the ENST00000449605.1, ASO3480 or ENST00000505175.1, respectively.

### Claim 4 (depends on 1)

The diagnostic kit according to claim 1, wherein the buffer contains SYBR Green.

### Claim 5 (depends on 1)

The diagnostic kit according to claim 1, wherein the kit is capable of using for real-time PCR.

### Claim 6 (depends on 1)

The diagnostic kit according to claim 1, wherein the subject is a pregnancy woman, the sample is a serum or plasma from the pregnancy woman.

### Claim 7 (depends on 1)

The diagnostic kit according to claim 1, wherein the kit comprises an instruction for using the kit to evaluate the intrahepatic cholestasis of pregnancy in the subject.

### Claim 8

A method for detecting an intrahepatic cholestasis of pregnancy comprising a step for detecting a LncRNA (Long non-coding RNA) marker in a sample of a subject, the LncRNA marker is ENST00000449605.1, ASO3480 or ENST00000505175.1.

### Claim 9 (depends on 8)

The method according to claim 8, wherein the ENST00000449605.1, ASO3480 and ENST00000505175.1 are RNAs whose cDNAs having DNA sequences shown as SEQ ID NO: 7, SEQ ID NO: 8 and SEQ ID NO: 9, respectively.

### Claim 10 (depends on 8)

The method according to claim 8, wherein the method is a PCR-based reaction that includes a reverse transcriptase, a DNA polymerase, dNTPs, a buffer and at least one pair of primers capable of amplifying one fragment of DNA from the cDNA of the ENST00000449605.1, ASO3480 and ENST00000505175.1.

### Claim 11 (depends on 10)

The method according to claim 10, wherein the pair of primers has the DNA sequences shown in SEQ ID No. 1 and SEQ ID No. 2, in SEQ ID No. 3 and SEQ ID No. 4 or in SEQ ID No. 5 and SEQ ID No. 6 which amplifies the fragment of DNA from the cDNA of the ENST00000449605.1, ASO3480 or ENST00000505175.1, respectively.

### Claim 12 (depends on 8)

The method according to claim 8, wherein the subject is a pregnancy woman, the sample is a serum or plasma from the pregnancy woman.

### Claim 13 (depends on 10)

The method according to claim 10, wherein comprises a step of analyzing results of the PCR-based reaction and evaluating the intrahepatic cholestasis of pregnancy in the subject.
